Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells

Fast gapped-read alignment with Bowtie 2

Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400 · see citing works

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · see citing works

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890 · see citing works

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179 · see citing works

Differential expression analysis for sequence count data

Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581 · see citing works

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400 · see citing works

Molecular and cellular insights into T cell exhaustion

Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652 · see citing works

Model-Based Clustering, Discriminant Analysis, and Density Estimation

Fraley, C., & Raftery, A. E. (2002) · Journal of the American Statistical Association · doi:10.1198/016214502760047131 · Cited by 4,274 · see citing works

Full-length RNA-seq from single cells using Smart-seq2

Picelli, S., Faridani, O. R., Björklund, Å. K., Winberg, G., Sagasser, S., & Sandberg, R. (2014) · Nature Protocols · doi:10.1038/nprot.2014.006 · Cited by 4,137 · see citing works

Cancer immunotherapy comes of age

Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893 · see citing works

Cancer stem cells revisited

Batlle, E., & Clevers, H. (2017) · Nature Medicine · doi:10.1038/nm.4409 · Cited by 2,769 · see citing works

Evolution of the Cancer Stem Cell Model

Kreso, A., & Dick, J. E. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.02.006 · Cited by 2,212 · see citing works

CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling

Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001 · see citing works

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

Tauriello, D. V. F., Palomo-Ponce, S., Stork, D., Berenguer-Llergo, A., Badia-Ramentol, J., Iglesias, M., Sevillano, M., Ibiza, S., Cañellas, A., Hernando-Momblona, X., et al. (2018) · Nature · doi:10.1038/nature25492 · Cited by 1,851 · see citing works

Adoptive immunotherapy for cancer: harnessing the T cell response

Restifo, N. P., Dudley, M. E., & Rosenberg, S. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3191 · Cited by 1,688 · see citing works

T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer

Tran, E., Robbins, P. F., Lu, Y.-C., Prickett, T. D., Gartner, J. J., Jia, L., Pasetto, A., Zheng, Z., Ray, S., Groh, E. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609279 · Cited by 1,368 · see citing works

Natural selection of tumor variants in the generation of “tumor escape” phenotypes

Khong, H. T., & Restifo, N. P. (2002) · Nature Immunology · doi:10.1038/ni1102-999 · Cited by 1,058 · see citing works

Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties

Schwitalla, S., Fingerle, A. A., Cammareri, P., Nebelsiek, T., Göktuna, S. İ., Ziegler, P. K., Canli, Ö., Heijmans, J., Huels, D. J., Moreaux, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.12.012 · Cited by 1,057 · see citing works

Notch1 functions as a tumor suppressor in mouse skin

Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C., Clevers, H. C., Dotto, G. P., & Radtke, F. (2003) · Nature Genetics · doi:10.1038/ng1099 · Cited by 969 · see citing works

Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies

Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J., & Allison, J. P. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082492 · Cited by 967 · see citing works

Essential role for oncogenic Ras in tumour maintenance

Chin, L., Tam, A., Pomerantz, J. H., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 928 · see citing works

T-cell regulation by CD28 and CTLA-4

Alegre, M., Frauwirth, K. A., & Thompson, C. B. (2001) · Nature reviews. Immunology · doi:10.1038/35105024 · Cited by 912 · see citing works

The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune Responses

Carreno, B. M., & Collins, M. A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.091101.091806 · Cited by 895 · see citing works

TGF-β Activation and Function in Immunity

Travis, M. A., & Sheppard, D. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120257 · Cited by 856 · see citing works

The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses

Walker, L. S. K., & Sansom, D. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri3108 · Cited by 786 · see citing works

SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma

Boumahdi, S., Driessens, G., Lapouge, G., Rorive, S., Nassar, D., Mercier, M. L., Delatte, B., Caauwe, A., Lenglez, S., Nkusi, E., et al. (2014) · Nature · doi:10.1038/nature13305 · Cited by 657 · see citing works

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

Landsberg, J., Sirokay, J. D., Renn, M., Bald, T., Rogava, M., Cron, M., Fatho, M., Lennerz, V., Wölfel, T., Hölzel, M., et al. (2012) · Nature · doi:10.1038/nature11538 · Cited by 635 · see citing works

TGF-β Tumor Suppression through a Lethal EMT

David, C. J., Huang, Y.-H., Chen, M., Su, J., Zou, Y., Bardeesy, N. M., Iacobuzio–Donahue, C. A., & Massagué, J. (2016) · Cell · doi:10.1016/j.cell.2016.01.009 · Cited by 597 · see citing works

CD80 (B7-1) Binds Both CD28 and CTLA-4 with a Low Affinity and Very Fast Kinetics

van der Merwe, P. A., Bodian, D. L., Daenke, S., Linsley, P., & Davis, S. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.393 · Cited by 551 · see citing works

Expression of tumour-specific antigens underlies cancer immunoediting

DuPage, M. J. P., Mazumdar, C., Schmidt, L., Cheung, A. F., & Jacks, T. (2012) · Nature · doi:10.1038/nature10803 · Cited by 529 · see citing works

TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma

Oshimori, N., Oristian, D., & Fuchs, E. (2015) · Cell · doi:10.1016/j.cell.2015.01.043 · Cited by 471 · see citing works

A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours

Beck, B., Driessens, G., Goossens, S., Youssef, K. K., Kuchnio, A., Caauwe, A., Sotiropoulou, P. A., Loges, S., Lapouge, G., Candi, A., et al. (2011) · Nature · doi:10.1038/nature10525 · Cited by 466 · see citing works

A model for RAS mutation patterns in cancers: finding the sweet spot

Li, S., Balmain, A., & Counter, C. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0076-6 · Cited by 384 · see citing works

Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic Melanoma

Mackensen, A., Meidenbauer, N., Vogl, S., Laumer, M., Berger, J., & Andreesen, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1100 · Cited by 297 · see citing works

Identifying the cellular origin of squamous skin tumors

Lapouge, G., Youssef, K. K., Vokaer, B., Achouri, Y., Michaux, C., Sotiropoulou, P. A., & Blanpain, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012720108 · Cited by 294 · see citing works

Response to self antigen imprints regulatory memory in tissues

Rosenblum, M. D., Gratz, I. K., Paw, J. S., Lee, K., Marshak‐Rothstein, A., & Abbas, A. K. (2011) · Nature · doi:10.1038/nature10664 · Cited by 281 · see citing works

Direct in Vivo RNAi Screen Unveils Myosin IIa as a Tumor Suppressor of Squamous Cell Carcinomas

Schramek, D., Sendoel, A., Segal, J. P., Beronja, S., Heller, E., Oristian, D., Reva, B. A., & Fuchs, E. V. (2014) · Science · doi:10.1126/science.1248627 · Cited by 269 · see citing works

Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7

Bremner, R., & Balmain, A. (1990) · Cell · doi:10.1016/0092-8674(90)90523-h · Cited by 264 · see citing works

Tumor-initiating stem cells of squamous cell carcinomas and their control by TGF-β and integrin/focal adhesion kinase (FAK) signaling

Schöber, M., & Fuchs, E. V. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107807108 · Cited by 261 · see citing works

Quiescent tissue stem cells evade immune surveillance

Agudo, J., Park, E. S., Rose, S. A., Alibo, E., Sweeney, R., Dhainaut, M., Kobayashi, K. S., Sachidanandam, R., Baccarini, A., Merad, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.02.001 · Cited by 244 · see citing works

Rapid functional dissection of genetic networks via tissue-specific transduction and RNAi in mouse embryos

Beronja, S., Livshits, G., Williams, S. E., & Fuchs, E. V. (2010) · Nature Medicine · doi:10.1038/nm.2167 · Cited by 209 · see citing works

An obligate cell-intrinsic function for CD28 in Tregs

Zhang, R., Huynh, A., Whitcher, G. H., Chang, J., Maltzman, J. S., & Turka, L. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65013 · Cited by 208 · see citing works

Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma

Nassar, D., Latil, M., Boeckx, B., Lambrechts, D., & Blanpain, C. (2015) · Nature Medicine · doi:10.1038/nm.3878 · Cited by 185 · see citing works

Defining the origins of Ras/p53-mediated squamous cell carcinoma

White, A. C., Tran, K. V., Khuu, J., Dang, C., Cui, Y., Binder, S. W., & Lowry, W. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012670108 · Cited by 185 · see citing works

PD-L1 Binds to B7-1 Only In Cis on the Same Cell Surface

Chaudhri, A., Xiao, Y., Klee, A. N., Wang, X., Zhu, B., & Freeman, G. J. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0316 · Cited by 177 · see citing works

RNAi screens in mice identify physiological regulators of oncogenic growth

Beronja, S., Janki, P., Heller, E., Lien, W., Keyes, B. E., Oshimori, N., & Fuchs, E. V. (2013) · Nature · doi:10.1038/nature12464 · Cited by 162 · see citing works

TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma

Brown, J. A., Yonekubo, Y., Hanson, N. C., Sastre-Perona, A., Basin, A., Rytlewski, J. A., Dolgalev, I., Meehan, S. A., Tsirigos, A., Beronja, S., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.001 · Cited by 161 · see citing works

TGF-β Inhibition and Immunotherapy: Checkmate

Ganesh, K., & Massagué, J. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.037 · Cited by 125 · see citing works

Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness

Lapouge, G., Beck, B., Nassar, D., Dubois, C., Dekoninck, S., & Blanpain, C. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.312 · Cited by 81 · see citing works

ETS family transcriptional regulators drive chromatin dynamics and malignancy in squamous cell carcinomas

Yang, H., Schramek, D., Adam, R. C., Keyes, B. E., Wang, P., Zheng, D., & Fuchs, E. V. (2015) · eLife · doi:10.7554/elife.10870 · Cited by 77 · see citing works

Novel CD28 antagonist mPEG PV1-Fab’ mitigates experimental autoimmune uveitis by suppressing CD4+ T lymphocyte activation and IFN-γ production

Papotto, P. H., Marengo, E. B., Sardinha, L. R., Carvalho, K. I., de Carvalho, A. E. Z., Castillo-Méndez, S. I., Jank, C. C., Vanhove, B., Goldberg, A. C., & Rizzo, L. V. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171822 · Cited by 12 · see citing works

Tumour-intrinsic resistance to immune checkpoint blockade

Kalbasi, A. K., & Ribas, A. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0218-4 · Cited by 1,491 · see citing works

Multimodal Analysis of Composition and Spatial Architecture in Human Squamous Cell Carcinoma

Ji, A. L., Rubin, A. J., Thrane, K., Jiang, S., Reynolds, D. L., Meyers, R. M., Guo, M. G., George, B. M., Mollbrink, A., Bergenstråhle, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.039 · Cited by 1,117 · see citing works

Intratumoral heterogeneity in cancer progression and response to immunotherapy

Vitale, I., Shema, E., Loi, S., & Galluzzi, L. (2021) · Nature Medicine · doi:10.1038/s41591-021-01233-9 · Cited by 823 · see citing works

Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update

Clara, J., Monge, C., Yang, Y., & Takebe, N. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752 · see citing works

Cancer stem cell–immune cell crosstalk in tumour progression

Bayık, D., & Lathia, J. D. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00366-w · Cited by 563 · see citing works

Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data

Sun, D., Guan, X., Moran, A. E., Wu, L., Qian, D. Z., Schedin, P. S., Dai, M., Danilov, A. V., Alumkal, J. J., Adey, A., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-01091-3 · Cited by 511 · see citing works

A single-cell landscape of high-grade serous ovarian cancer

Izar, B., Tirosh, I., Stover, E. H., Wakiro, I., Cuoco, M. S., Alter, I., Rodman, C., Leeson, R. L., Su, M.-J., Shah, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0926-0 · Cited by 508 · see citing works

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant

Yang, C. Q., Xia, B.-R., Zhang, Z.-C., Zhang, Y., Lou, G., & Jin, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.577869 · Cited by 354 · see citing works

Cancer cell plasticity during tumor progression, metastasis and response to therapy

Pérez-González, A., Bévant, K., & Blanpain, C. (2023) · Nature Cancer · doi:10.1038/s43018-023-00595-y · Cited by 353 · see citing works

Hallmarks of cancer stemness

Loh, J.-J., & Ma, S. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.04.004 · Cited by 327 · see citing works

CD276 expression enables squamous cell carcinoma stem cells to evade immune surveillance

Wang, C., Li, Y., Jia, L., Kim, J. K., Li, J., Deng, P., Zhang, W., Krebsbach, P. H., & Wang, C. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.04.011 · Cited by 314 · see citing works

Persistent Cancer Cells: The Deadly Survivors

Shen, S., Vagner, S., & Robert, C. (2020) · Cell · doi:10.1016/j.cell.2020.10.027 · Cited by 304 · see citing works

Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration

Li, Z., Shan, X., Chen, Z., Gao, N., Zeng, W., Zeng, X., & Mei, L. (2020) · Advanced Science · doi:10.1002/advs.202002589 · Cited by 219 · see citing works

Targeting carnitine palmitoyl transferase 1A (CPT1A) induces ferroptosis and synergizes with immunotherapy in lung cancer

Ma, L., Chen, C., Zhao, C., Li, T., Ma, L., Jiang, J., Duan, Z., Si, Q., Chuang, T., Xiang, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01772-w · Cited by 217 · see citing works

Cancer drug-tolerant persister cells: from biological questions to clinical opportunities

Russo, M., Chen, M., Mariella, E., Peng, H., Rehman, S. K., Sancho, E., Sogari, A., Toh, T. S., Balaban, N. Q., Batlle, E., et al. (2024) · Nature Reviews Cancer · doi:10.1038/s41568-024-00737-z · Cited by 210 · see citing works

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance

Angelis, M. L. D., Francescangeli, F., Torre, F. L., & Zeuner, A. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00626 · Cited by 203 · see citing works

Understanding tumour endothelial cell heterogeneity and function from single-cell omics

Zeng, Q., Mousa, M., Nadukkandy, A. S., Franssens, L., Alnaqbi, H., Alshamsi, F., Safar, H. A., & Carmeliet, P. (2023) · Nature Reviews. Cancer · doi:10.1038/s41568-023-00591-5 · Cited by 196 · see citing works

Drug-tolerant persister cells in cancer: the cutting edges and future directions

Pu, Y., Li, L., Peng, H., Liu, L., Heymann, D., Robert, C., Vallette, F. M., & Shen, S. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00815-5 · Cited by 179 · see citing works

Beyond genetics: driving cancer with the tumour microenvironment behind the wheel

Yuan, S., Almagro, J., & Fuchs, E. V. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-023-00660-9 · Cited by 178 · see citing works

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment

Wu, B., Shi, X., Jiang, M., & Liu, H. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01748-4 · Cited by 173 · see citing works

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis

Xu, K., Wang, R., Xie, H., Hu, L., Wang, C., Xu, J., Zhu, C., Liu, Y., Gao, F., Li, X., et al. (2021) · Oncogenesis · doi:10.1038/s41389-021-00355-6 · Cited by 166 · see citing works

Breast cancer cell-derived extracellular vesicles promote CD8+ T cell exhaustion via TGF-β type II receptor signaling

Xie, F., Zhou, X., Su, P., Li, H., Tu, Y., Du, J., Pan, C., Xiang, W. D., Zheng, M., Jin, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31250-2 · Cited by 164 · see citing works

Cancer stem cell mimicry for immune evasion and therapeutic resistance

Saw, P. E., Liu, Q., Wong, P., & Song, E. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.06.003 · Cited by 164 · see citing works

5-hydroxytryptamine produced by enteric serotonergic neurons initiates colorectal cancer stem cell self-renewal and tumorigenesis

Zhu, P., Lu, T., Chen, Z., Liu, B., Fan, D., Li, C., Wu, J., He, L., Zhu, X., Du, Y., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.04.024 · Cited by 160 · see citing works

BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse

Jia, L., Zhang, W., & Wang, C. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.06.022 · Cited by 158 · see citing works

Stem cell quiescence: the challenging path to activation

Urbán, N., & Cheung, T. H. (2021) · Development · doi:10.1242/dev.165084 · Cited by 154 · see citing works

Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

Valle, S., Alcalá, S., Martín-Hijano, L., Cabezas‐Sainz, P., Navarro, D., Muñoz, E. R., Yuste, L., Tiwary, K., Walter, K., Ruíz-Cañas, L., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18954-z · Cited by 153 · see citing works

Laser-induced graphene (LIG)-based Au@CuO/V2CTx MXene non-enzymatic electrochemical sensors for the urine glucose test

Cui, F., Sun, H., Yang, X., Zhou, H., Wu, Y., Li, J., Li, H., Liu, J., Zeng, C., Qu, B., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.141303 · Cited by 146 · see citing works

Advances in cutaneous squamous cell carcinoma

Winge, M. C. G., Kellman, L. N., Guo, K., Tang, J. Y., Swetter, S. M., Aasi, S. Z., Sarin, K. Y., Chang, A. L. S., & Khavari, P. A. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00583-5 · Cited by 149 · see citing works

Targeting CMTM6 Suppresses Stem Cell–Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma

Chen, L., Yang, Q., Li, Y., Yang, L., Liu, J., Li, H., Xiao, Y., Bu, L., Zhang, W., & Sun, Z. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0394 · Cited by 144 · see citing works

Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response

von Locquenghien, M., Rozalén, C., & Celià-Terrassa, T. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143296 · Cited by 144 · see citing works

circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation

Jia, L., Wang, Y., & Wang, C. (2021) · Advanced Science · doi:10.1002/advs.202003376 · Cited by 144 · see citing works

Slow-cycling (dormant) cancer cells in therapy resistance, cancer relapse and metastasis

Basu, S., Yang, D. Y., Kumar, R., Jeter, C. R., & Tang, D. G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.021 · Cited by 142 · see citing works

Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells

Perry, J. M., Fang, T., Roy, A., Lin, T. L., He, X., Chen, S., Lü, X., Nemechek, J. M., Ruan, L., Yu, X., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0507-y · Cited by 137 · see citing works

Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance

Wei, F., Wang, D., Wei, J., Tang, N., Tang, L. M., Xiong, F., Guo, C. J., Zhou, M., Li, X., Li, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03581-0 · Cited by 128 · see citing works

Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers

Lei, M. M. L., & Lee, T. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.692940 · Cited by 123 · see citing works

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

Musella, M., Guarracino, A., Manduca, N., Galassi, C., Ruggiero, E., Potenza, A., Maccafeo, E., Manic, G., Mattiello, L., Rehim, S. S. A., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01290-3 · Cited by 122 · see citing works

The influence of microenvironment on tumor immunotherapy

Zhang, J., Shi, Z., Xu, X., Yu, Z., & Mi, J. (2019) · FEBS Journal · doi:10.1111/febs.15028 · Cited by 112 · see citing works

Fighting Drug Resistance through the Targeting of Drug-Tolerant Persister Cells

De Conti, G., Dias, M. H., & Bernards, R. (2021) · Cancers · doi:10.3390/cancers13051118 · Cited by 111 · see citing works

Recent progress in tumor photodynamic immunotherapy

Shen, L., Zhou, T., Fan, Y., Chang, X. Y., Wang, Y., Sun, J., Xing, L., & Jiang, H. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.02.007 · Cited by 105 · see citing works

Cancer stem cells and niches: challenges in immunotherapy resistance

Pan, Y., Yuan, C., Zeng, C., Sun, C., Xia, L., Wang, G., Chen, X., Zhang, B., Liu, J., & Ding, Z. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02265-2 · Cited by 110 · see citing works

Combinatorial Photothermal 3D‐Printing Scaffold and Checkpoint Blockade Inhibits Growth/Metastasis of Breast Cancer to Bone and Accelerates Osteogenesis

He, C., Yu, L., Yao, H., Chen, Y., & Hao, Y. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202006214 · Cited by 101 · see citing works

Convergent inducers and effectors of T cell paralysis in the tumour microenvironment

Hanahan, D., Michielin, O. A., & Pittet, M. J. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00761-z · Cited by 102 · see citing works

Single-cell RNA sequencing in cancer: Applications, advances, and emerging challenges

Sun, G., Li, Z., Rong, D., Zhang, H., Shi, X., Yang, W., Zheng, W., Sun, G., Wu, F., Cao, H., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.04.001 · Cited by 104 · see citing works

The Role of the Microenvironment and Immune System in Regulating Stem Cell Fate in Cancer

Ferguson, L. P., Diaz, E., & Reya, T. (2021) · Trends in cancer · doi:10.1016/j.trecan.2020.12.014 · Cited by 96 · see citing works

Platelet-armored nanoplatform to harmonize janus-faced IFN-γ against tumor recurrence and metastasis

Li, Q., Zhou, Y., He, W., Ren, X., Zhang, M., Jiang, Y., Zhou, Z., & Luan, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.08.020 · Cited by 93 · see citing works

Adult stem cells and regenerative medicine—a symposium report

Cable, J., Fuchs, E. V., Weissman, I. L., Jasper, H., Glass, D. J., Rando, T. A., Blau, H. M., Debnath, S., Oliva, A. A., Park, S., et al. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14243 · Cited by 93 · see citing works

Oncofetal reprogramming in tumour development and progression

Sharma, A., Blériot, C., Currenti, J., & Ginhoux, F. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00497-8 · Cited by 95 · see citing works

Ras drives malignancy through stem cell crosstalk with the microenvironment

Yuan, S., Stewart, K. S., Yang, Y., Abdusselamoglu, M. D., Parigi, S. M., Feinberg, T. Y., Tumaneng, K., Yang, H., Levorse, J. M., Polak, L., et al. (2022) · Nature · doi:10.1038/s41586-022-05475-6 · Cited by 92 · see citing works

CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5‐LSD1‐NF‐κB oncogenic signaling

Hu, B., Xu, Y., Li, Y., Huang, J., Cheng, J., Guo, W., Yin, Y., Gao, Y., Wang, P., Wu, S., et al. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.233 · Cited by 87 · see citing works

Cancer Immunotherapy via Targeting Cancer Stem Cells Using Vaccine Nanodiscs

Najafabadi, A. H., Zhang, J., Aikins, M. E., Najafabadi, Z. I., Liao, F., Qin, Y., Okeke, E. B., Scheetz, L. M., Nam, J., Xu, Y., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c03414 · Cited by 86 · see citing works

MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer

Yamashita, N., Long, M. D., Fushimi, A., Yamamoto, M., Hata, T., Hagiwara, M., Bhattacharya, A., Hu, Q., Wong, K., Liu, S., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-002115 · Cited by 83 · see citing works

Circular RNA cia-MAF drives self-renewal and metastasis of liver tumor-initiating cells via transcription factor MAFF

Chen, Z., Lu, T., Huang, L., Wang, Z., Yan, Z., Guan, Y., Hu, W., Fan, Z., & Zhu, P. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148020 · Cited by 85 · see citing works

Targeting cancer stem cells in squamous cell carcinoma

Chen, D., & Wang, C. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz016 · Cited by 81 · see citing works

Tumor-initiating stem cell shapes its microenvironment into an immunosuppressive barrier and pro-tumorigenic niche

He, X., Smith, S. E., Chen, S., Li, H., Wu, D., Meneses-Giles, P., Wang, Y., Hembree, M. J., Yi, K., Zhao, X., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109674 · Cited by 79 · see citing works

Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations

Chen, X., Chen, L., Peng, X., Deng, L., Wang, Y., Li, J.-J., Guo, D., & Niu, X. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101851 · Cited by 80 · see citing works

EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer

Liu, X., Adorno-Cruz, V., Chang, Y.-F., Jia, Y., Kawaguchi, M., Dashzeveg, N. K., Taftaf, R., Ramos, E. K., Schuster, E. J., El-Shennawy, L., et al. (2021) · Theranostics · doi:10.7150/thno.57706 · Cited by 76 · see citing works

Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy

Dianat‐Moghadam, H., Mahari, A., Salahlou, R., Khalili, M., Azizi, M., & Sadeghzadeh, H. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02829-9 · Cited by 80 · see citing works

ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis

Adorno-Cruz, V., Hoffmann, A. D., Liu, X., Dashzeveg, N. K., Taftaf, R., Wray, B. D., Keri, R. A., & Liu, H. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.01.015 · Cited by 77 · see citing works

TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer

Cheng, X., Fan, K., Wang, L., Ying, X., Sanders, A. J., Guo, T., Xing, X., Zhou, M., Du, H., Hu, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2272-z · Cited by 75 · see citing works

IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy

Beziaud, L., Young, C. M., Alonso, A. M., Norkin, M., Minafra, A. R., & Huelsken, J. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.007 · Cited by 76 · see citing works

Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions

Granhøj, J. S., Jensen, A. W. P., Presti, M., Met, Ö., Svane, I. M., & Donia, M. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2064711 · Cited by 74 · see citing works

Risk-associated alterations in marrow T cells in pediatric leukemia

Bailur, J. K., McCachren, S. S., Pendleton, K. E., Vasquez, J. C., Lim, H. S., Duffy, A. M., Doxie, D. B., Kaushal, A., Foster, C., DeRyckere, D., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.140179 · Cited by 73 · see citing works

Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy

Yang, C. G., Geng, H., Yang, X., Ji, S., Liu, Z., Feng, H., Li, Q., Zhang, T., Zhang, S., Ma, X., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.10.008 · Cited by 74 · see citing works

Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression

Dolina, J. S., Lee, J., Brightman, S. E., McArdle, S., Hall, S. M., Thota, R. R., Zavala, K. S., Lanka, M., Premlal, A. L. R., Greenbaum, J., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164258 · Cited by 68 · see citing works

LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer

Pérez-Núñez, I., Rozalén, C., Palomeque, J. Á., Sangrador, I., Dalmau, M., Comerma, L., Hernández-Prat, A., Casadevall, D., Menéndez, S., Liu, D., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00339-4 · Cited by 63 · see citing works

Cancer biology deciphered by single-cell transcriptomic sequencing

Li, Y., Jin, J., & Bai, F. (2021) · Protein & Cell · doi:10.1007/s13238-021-00868-1 · Cited by 67 · see citing works

A Review of the Role of Wnt in Cancer Immunomodulation

Goldsberry, W. N., Londoño, A. I., Randall, T. D., Norian, L. A., & Arend, R. C. (2019) · Cancers · doi:10.3390/cancers11060771 · Cited by 66 · see citing works

mcPGK1-dependent mitochondrial import of PGK1 promotes metabolic reprogramming and self-renewal of liver TICs

Chen, Z., He, Q., Lu, T., Wu, J., Shi, G., He, L., Zong, H., Liu, B., & Zhu, P. (2023) · Nature Communications · doi:10.1038/s41467-023-36651-5 · Cited by 66 · see citing works

Application of Single-Cell Multi-Omics in Dissecting Cancer Cell Plasticity and Tumor Heterogeneity

Pan, D., & Jia, D. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.757024 · Cited by 64 · see citing works

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy

He, J., Zhou, Y. L., & Sun, L. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01438-0 · Cited by 69 · see citing works

Midbrain microglia mediate a specific immunosuppressive response under inflammatory conditions

Abellanas, M. A., Zamarbide, M., Basurco, L., Luquin, E., García‐Granero, M., Clavero, P., Martín‐Úriz, P. S., Vilas‐Zornoza, A., Mengual, E., Hervás‐Stubbs, S., et al. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1628-8 · Cited by 64 · see citing works

A Metabolic Reprogramming Amino Acid Polymer as an Immunosurveillance Activator and Leukemia Targeting Drug Carrier for T‐Cell Acute Lymphoblastic Leukemia

Li, C., You, X., Xu, X., Wu, B., Liu, Y., Tong, T., Chen, J., Li, Y., Dai, C., Ye, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202104134 · Cited by 63 · see citing works

Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints

Hargadon, K. M. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.37 · Cited by 61 · see citing works

Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer

Miyazaki, T., Chung, S., Sakai, H., Ohata, H., Obata, Y., Shiokawa, D., Mizoguchi, Y., Kubo, T., Ichikawa, H., Taniguchi, H., et al. (2021) · Cancer Science · doi:10.1111/cas.15182 · Cited by 60 · see citing works

Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy

Rouzbahani, E., Majidpoor, J., Najafi, S., & Mortezaee, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113906 · Cited by 62 · see citing works

The association between tumour heterogeneity and immune evasion mechanisms in hepatocellular carcinoma and its clinical implications

Chen, K., Shuen, T. W. H., & Chow, P. K. H. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02684-w · Cited by 60 · see citing works

T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity

Canel, M., Taggart, D., Sims, A. H., Lonergan, D. W., Waizenegger, I. C., & Serrels, A. (2020) · eLife · doi:10.7554/elife.48092 · Cited by 58 · see citing works

Pan-TGFβ inhibition by SAR439459 relieves immunosuppression and improves antitumor efficacy of PD-1 blockade

Greco, R., Qu, H., Qu, H., Theilhaber, J., Shapiro, G., Gregory, R. C., Winter, C. G., Malkova, N. V., Sun, F. F., Jaworski, J. A., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1811605 · Cited by 58 · see citing works

The multi-molecular mechanisms of tumor-targeted drug resistance in precision medicine

Li, X., Li, M., Huang, M., Lin, Q., Fang, Q., Liu, J., Chen, X., Liu, L., Zhan, X., Shan, H., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113064 · Cited by 56 · see citing works

Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial

Choueiri, T. K., Larkin, J., Pal, S. K., Motzer, R. J., Rini, B. I., Venugopal, B., Alekseev, B. Y., Miyake, H., Gravis, G., Bilen, M. A., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100101 · Cited by 55 · see citing works

Stemness in solid malignancies: coping with immune attack

Agudo, J., & Miao, Y. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00760-0 · Cited by 54 · see citing works

Targeting Myc-driven stress addiction in colorectal cancer

Saeed, H., Leibowitz, B. J., Zhang, L., & Yu, J. (2023) · Drug Resistance Updates · doi:10.1016/j.drup.2023.100963 · Cited by 53 · see citing works

Cell Death Pathway Regulation by Functional Nanomedicines for Robust Antitumor Immunity

Li, Y., Guo, Y., Zhang, K., Zhu, R., Chen, X. S., Zhang, Z., & Yang, W. (2023) · Advanced Science · doi:10.1002/advs.202306580 · Cited by 51 · see citing works

How Tumor Cell Dedifferentiation Drives Immune Evasion and Resistance to Immunotherapy

Li, J., & Stanger, B. Z. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-1420 · Cited by 50 · see citing works

Targeting LSD1 suppresses stem cell-like properties and sensitizes head and neck squamous cell carcinoma to PD-1 blockade

Han, Y., Xu, S., Ye, W., Wang, Y., Zhang, X., Deng, J., Zhang, Z., Liu, L., & Liu, S. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04297-0 · Cited by 49 · see citing works

Circular RNAs in tumor immunity and immunotherapy

Zhang, W., Chen, X., Yang, Z., Zhou, J., Peng, W., Zhang, X., Li, H., Qu, S., & Tao, K. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02082-z · Cited by 51 · see citing works

Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor

Ducarouge, B., Redavid, A. R., Victoor, C., Chira, R., Fonseca, A., Hervieu, M., Bergé, R., Lengrand, J., Vieugué, P., Neves, D., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01209-x · Cited by 46 · see citing works

YAP1 induces bladder cancer progression and promotes immune evasion through IL-6/STAT3 pathway and CXCL deregulation

Sadhukhan, P., Feng, M., Illingworth, E. J., Sloma, I., Ooki, A., Matoso, A., Sidransky, D., Johnson, B. A., Marchionni, L., Sillé, F. C. M., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci171164 · Cited by 47 · see citing works

An emerging role for cellular crosstalk in the cancer stem cell niche

Oshimori, N., Guo, Y., & Taniguchi, S. (2021) · The Journal of Pathology · doi:10.1002/path.5655 · Cited by 47 · see citing works

Immunotargeting of Cancer Stem Cells

Köseer, A. S., Gaetano, S. D., Arndt, C., Bachmann, M. P., & Dubrovska, A. (2023) · Cancers · doi:10.3390/cancers15051608 · Cited by 46 · see citing works

The Love-Hate Relationship Between TGF-β Signaling and the Immune System During Development and Tumorigenesis

Chen, B., Mu, C., Zhang, Z., He, X., & Liu, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891268 · Cited by 46 · see citing works

Small cell lung cancer stem cells display mesenchymal properties and exploit immune checkpoint pathways in activated cytotoxic T lymphocytes

Kursunel, M. A., Taşkıran, E. Z., Tavukçuoğlu, E., Yanık, H., Demirağ, F., Karaosmanoğlu, B., Kurt, F. G. Ö., Üner, A., Esendagli, D. R., Kızılgöz, D., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02998-1 · Cited by 42 · see citing works

A tumor-associated splice-isoform of MAP2K7 drives dedifferentiation in MBNL1-low cancers via JNK activation

Ray, D., Yun, Y. C., Idris, M., Cheng, S., Boot, A., Iain, T. B. H., Rozen, S., Tan, P. B. O., & Epstein, D. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2002499117 · Cited by 42 · see citing works

Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer

Moutafi, M. K., Molero-Abraham, M., Martínez-Morilla, S., Baena, J., Vathiotis, I. A., Gavrielatou, N., Castro‐Labrador, L., Ponce, G. R. D. G., Adradas, V., Orive, D., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004757 · Cited by 42 · see citing works

SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming

Xu, X., Yu, Y., Zhang, W., Ma, W., He, C., Qiu, G., Wang, X., Liu, Q., Zhao, M.-Y., Xie, J.-Y., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01349-3 · Cited by 38 · see citing works

Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models

Xuan, Y., Sheng, Y., Zhang, D., Zhang, K., Zhang, Z., Yü, P., Wang, S., Shi, X., Lian, J., Liu, K., et al. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101138 · Cited by 39 · see citing works

Sniping Cancer Stem Cells with Nanomaterials

Wang, W.-D., Guo, Y., Yang, Z., Su, G.-L., & Sun, Z. (2023) · ACS Nano · doi:10.1021/acsnano.3c07828 · Cited by 38 · see citing works

Minimal Residual Disease, Metastasis and Immunity

Badia-Ramentol, J., Linares, J., Gómez‐Llonín, A., & Calon, A. (2021) · Biomolecules · doi:10.3390/biom11020130 · Cited by 39 · see citing works

Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated

Mortezaee, K., Majidpoor, J., & Kharazinejad, E. (2022) · Medical Oncology · doi:10.1007/s12032-022-01801-0 · Cited by 38 · see citing works

Abstract A093: Immune resistance emerges from tumor-initiating stem cells

Miao, Y., & Fuchs, E. V. (2019) · Cancer Immunology Research · doi:10.1158/2326-6074.cricimteatiaacr18-a093

Abstract 1491: Immune resistance emerges from tumor-initiating stem cells

Miao, Y. (2019) · Immunology · doi:10.1158/1538-7445.sabcs18-1491

Abstract 3086: Decoding the intimate dialogues between stem cells and immune cell for cancer immunotherapy

Truong, C., Guo, W., Rudensky, A. Y., Fuchs, E. V., & Miao, Y. (2021) · Cancer Research · doi:10.1158/1538-7445.am2021-3086

0813 Epidermal cancer stem cells establish intrinsic immune resistance through suppressing IFN-mediated antitumor immunity

Huang, X., Guo, W., & Miao, Y. (2026) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2026.06.844

Abstract SY42-01: Tumor-initiating stem cells shape the microenvironment into an immunosuppressive barrier and a pro-tumorigenic niche

Li, L. (2022) · Cancer Research · doi:10.1158/1538-7445.am2022-sy42-01